Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

The Effects of Two Types of t-DCS Stimulation on Robot-assisted Gait Training in Patients With Multiple SclerosisUnknown
NCT06121635NAUpdated May 20, 2024
Sponsor: Istanbul Medeniyet University
Multiple Sclerosis · Transcranial Direct Current Stimulation
Turkey (Türkiye)
Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.Unknown
NCT04595799N/AUpdated May 17, 2024
Sponsor: Centre Hospitalier Universitaire de Nice
Multiple Sclerosis
France
LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMABActive Not Recruiting
NCT05210621Phase 3Updated May 17, 2024
Sponsor: Centre Hospitalier Universitaire de Nice
Multiple Sclerosis
France
Trial of eHealth Wellness Behavioral Interventions and Patient-reported OutcomesCompleted
NCT05442112NAUpdated May 17, 2024
Sponsor: Johns Hopkins University
Multiple Sclerosis
United States
A Study for Tysabri Participant PreferenceCompleted
NCT05304520N/AUpdated May 17, 2024
Sponsor: Biogen
Relapsing-Remitting Multiple Sclerosis (RRMS)
Germany
A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue DamageCompleted
NCT05106465N/AUpdated May 17, 2024
Sponsor: Biogen
Multiple Sclerosis (MS)
Germany
Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple SclerosisCompleted
NCT04688710NAUpdated May 17, 2024
Sponsor: University of Washington
Multiple Sclerosis · Fatigue
United States
Home-based Balance Training in Adults With Multiple SclerosisUnknown
NCT06412003NAUpdated May 16, 2024
Sponsor: University of Vermont
Multiple Sclerosis · Multiple Sclerosis, MS
Prescription Drug Safety and Effectiveness in Multiple SclerosisCompleted
NCT04472975N/AUpdated May 16, 2024
Sponsor: University of British Columbia
Multiple Sclerosis
Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS RelapsesTerminated
NCT03021317Phase 4Updated May 16, 2024
Sponsor: University of Chicago
Multiple Sclerosis
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC InfantsCompleted
NCT04595513Phase 1, Phase 2Updated May 16, 2024
Sponsor: Children's Hospital Medical Center, Cincinnati
Tuberous Sclerosis Complex · Epilepsy
United States
The Effect of a Mindfulness-Based Stress Reduction Program in Patients With Multiple SclerosisCompleted
NCT06416176NAUpdated May 16, 2024
Sponsor: Halic University
Multiple Sclerosis · Mindfulness · Upper Motor Neuron Lesion
Turkey (Türkiye)
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With MayzentRecruiting
NCT04933552N/AUpdated May 16, 2024
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple SclerosisRecruiting
NCT03981003N/AUpdated May 14, 2024
Sponsor: Centre Hospitalier Universitaire de Nīmes
Multiple Sclerosis
France, Martinique
Mapping the Longitudinal, Multidimensional Impact of MS in Relation to Variables Indicative of Neurological ReserveCompleted
NCT06410326N/AUpdated May 13, 2024
Sponsor: National MS Center Melsbroek
Multiple Sclerosis
Belgium
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung CancerCompleted
NCT06136923NAUpdated May 13, 2024
Sponsor: Click Therapeutics, Inc.
Multiple Sclerosis · Lung Cancer · Breast Cancer
United States
Remote Ischemic Conditioning in PPMSNot Yet Recruiting
NCT06171334NAUpdated May 9, 2024
Sponsor: University of Calgary
Multiple Sclerosis
Canada
Repetitive Transcranial Magnetic Stimulation for Lower Limb Spasticity in Multiple Sclerosis PatientsSuspended
NCT02747914NAUpdated May 9, 2024
Sponsor: University of Belgrade
Multiple Sclerosis
Serbia
Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple SclerosisTerminated
NCT04203498Phase 3Updated May 8, 2024
Sponsor: Jazz Pharmaceuticals
Multiple Sclerosis (MS)
United States, Czechia, Poland, Romania, United Kingdom
Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple SclerosisUnknown
NCT05920018NAUpdated May 8, 2024
Sponsor: Universität Münster
Multiple Sclerosis, Relapsing-Remitting
Germany
Be Cool: An Innovative and Holistic Psychoeducational Program for Multiple Sclerosis IndividualsCompleted
NCT06248281N/AUpdated May 8, 2024
Sponsor: University of Thessaly
Multiple Sclerosis
Greece
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesUnknown
NCT05635266N/AUpdated May 7, 2024
Sponsor: Sanguine Biosciences
Age-Related Macular Degeneration · Allergies · Alpha-Gal Syndrome · Alzheimer Disease
United States
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple SclerosisRecruiting
NCT05832515Phase 1Updated May 7, 2024
Sponsor: St. Petersburg State Pavlov Medical University
Multiple Sclerosis
Russia
Improving the Effect of Multiple Sclerosis Drugs by ChronobiologyCompleted
NCT06385197NAUpdated May 6, 2024
Sponsor: Hadassah Medical Organization
Multiple Sclerosis
Israel
Telerehabilitation in Multiple SclerosisUnknown
NCT03444454NAUpdated May 3, 2024
Sponsor: Fondazione Don Carlo Gnocchi ETS
Multiple Sclerosis
Italy

Previous page Next page